Randomized Phase II Study of Suramin and Docetaxel Versus Docetaxel in Non-Small Cell Lung Cancer After Failure of First-Line Chemotherapy
Latest Information Update: 13 May 2020
At a glance
- Drugs Suramin sodium (Primary) ; Docetaxel
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 07 May 2020 Status changed from active, no longer recruiting to completed.
- 05 Aug 2016 Planned End Date changed from 1 Jun 2016 to 1 Dec 2016.
- 10 May 2016 Planned End Date changed from 1 Apr 2016 to 1 Jun 2016.